ASP Isotopes (NASDAQ:ASPI) Shares Up 3.8% – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI) rose 3.8% during trading on Thursday . The company traded as high as $11.09 and last traded at $10.76. Approximately 7,015,640 shares were traded during mid-day trading, a decline of 36% from the average daily volume of 10,964,385 shares. The stock had previously closed at $10.37.

Wall Street Analysts Forecast Growth

ASPI has been the subject of a number of recent analyst reports. Loop Capital set a $15.00 price objective on ASP Isotopes in a report on Monday. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Wednesday, September 17th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of ASP Isotopes in a research report on Thursday. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, ASP Isotopes has a consensus rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Stock Performance

The company has a quick ratio of 14.56, a current ratio of 14.72 and a debt-to-equity ratio of 3.53. The firm has a market capitalization of $1.01 billion, a P/E ratio of -8.47 and a beta of 3.29. The stock has a fifty day moving average of $9.80 and a 200-day moving average of $8.50.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.92). The company had revenue of $1.20 million for the quarter, compared to analyst estimates of $1.60 million. ASP Isotopes had a negative return on equity of 239.22% and a negative net margin of 2,181.62%. On average, research analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Activity at ASP Isotopes

In related news, Director Duncan Moore sold 75,000 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $9.28, for a total value of $696,000.00. Following the completion of the sale, the director directly owned 994,553 shares in the company, valued at $9,229,451.84. The trade was a 7.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Robert Ainscow sold 22,500 shares of the business’s stock in a transaction on Tuesday, October 14th. The shares were sold at an average price of $13.60, for a total value of $306,000.00. Following the completion of the sale, the chief executive officer owned 1,647,193 shares of the company’s stock, valued at $22,401,824.80. This trade represents a 1.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 406,199 shares of company stock worth $3,718,977 in the last three months. 21.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On ASP Isotopes

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Ameritas Investment Partners Inc. raised its holdings in shares of ASP Isotopes by 41.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after buying an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. SBI Securities Co. Ltd. raised its holdings in shares of ASP Isotopes by 84.8% during the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company’s stock worth $44,000 after buying an additional 4,299 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of ASP Isotopes by 96.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock worth $80,000 after buying an additional 5,353 shares in the last quarter. Finally, Bosun Asset Management LLC acquired a new position in shares of ASP Isotopes during the 1st quarter worth $103,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.